Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Influenza virus type a, Influenza virus type b
- Strength
- 32000000 FFU / 0.2 ML + 32000000 FFU / 0.2 ML + 32000000 FFU / 0.2 ML
- Dosage form
- Spray
- Route
- Nasal
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 26 Oct 2010
- Registration
- DIN 02352621
- Marketing authorisation holder
- Astrazeneca Canada INC
- ATC code
- J07BB03
- Supply
- SCHEDULE D